Praxis to present ulixacaltamide essential tremor data at AAN 2026

April 13, 2026 8:01 AM

Praxis Precision Medicines Inc. (NASDAQ: PRAX) announced it will present data from its Essential3 Phase 3 program for ulixacaltamide at ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found